Pre- and postnatal chemical mixture exposure, adolescent sleep health, and allostatic load
Project Number5R01ES035133-02
Contact PI/Project LeaderSEARS, CLARA G
Awardee OrganizationUNIVERSITY OF LOUISVILLE
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
A majority of U.S. adolescents are not getting sufficient sleep for optimal health. Sleep health is critical during
adolescence because of rapid neurodevelopment, growth, and body composition changes. Moreover,
inadequate and poor-quality sleep can increase allostatic load, or cumulative physiological ‘wear and tear’, from
disruptions across multiple regulatory systems that coordinate immune, cardiovascular, and metabolic function.
Evidence indicates that developmental exposures to ubiquitous environmental toxicants may disrupt
neurobiological mechanisms that regulate sleep and allostasis. However, whether these exposures are
modifiable risk factors for poor sleep during adolescence has not been rigorously examined. Our multidisciplinary
project brings together experts in pediatric environmental health, sleep, and cardiometabolic health to identify
whether early life exposure to environmental toxicant mixtures disrupts adolescent sleep health and increases
allostatic load. This project focuses on mixtures of phthalates, per-/polyfluoroalkyl substances (PFAS), and
metals. Most pregnant people, infants, and children are exposed to mixtures of these toxicants through diet and
consumer goods. The project leverages existing and new data from two well-characterized prospective
pregnancy and birth cohorts, the Health Outcomes and Measures of the Environment (HOME) Study and the
Maternal-Infant Research on Environmental Chemicals (MIREC) Study. Both cohorts previously enrolled
pregnant women and followed children until ages 7-9 (MIREC n=300) or 10-12 (HOME n=256) years with
additional visits underway at ages 10-12 (MIREC) and 16-18 (HOME) years. Sleep characteristics will be
examined at two timepoints in both cohorts using actigraphy. We will quantify relations between environmental
toxicant biomarkers during gestation, early childhood, school age, and adolescence with sleep characteristics
(Aim 1) and allostatic load (Aim 2) during adolescence. We will also examine whether exposure to environmental
toxicant mixtures is associated with hypothalamus-pituitary-adrenal (HPA) activity, catecholamines, and
systemic inflammation, biological intermediates of sleep-wake regulation and allostasis (Aim 3). Our analyses
will identify individual and joint effects of environmental toxicant mixtures and examine periods of heightened
susceptibility during critical developmental periods. Identifying modifiable environmental factors that contribute
to poor sleep health and allostatic load may inform novel interventions to reduce the risk of cardiovascular
disease, the leading cause of morbidity and mortality in adulthood worldwide.
Public Health Relevance Statement
PROJECT NARRATIVE
Exposure to environmental toxicants during early life development may negatively impact sleep health during
adolescence. This project will examine whether mixtures of phthalates, per-/polyfluoroalkyl substances (PFAS),
and metals during gestation, infancy, childhood, and adolescent development are related to poorer sleep and
higher allostatic load, cumulative ‘wear and tear’ from physiological disruptions. Understanding whether
environmental toxicants that are commonly found in consumer products and residential environments impact
sleep characteristics may lay the foundation for novel interventions to improve health.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
057588857
UEI
E1KJM4T54MK6
Project Start Date
12-September-2023
Project End Date
30-June-2028
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$441,071
Direct Costs
$324,279
Indirect Costs
$116,792
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$95,562
2024
National Institute of General Medical Sciences
$345,509
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01ES035133-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01ES035133-02
Patents
No Patents information available for 5R01ES035133-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01ES035133-02
Clinical Studies
No Clinical Studies information available for 5R01ES035133-02
News and More
Related News Releases
No news release information available for 5R01ES035133-02
History
No Historical information available for 5R01ES035133-02
Similar Projects
No Similar Projects information available for 5R01ES035133-02